The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period
Saved in:
Main Author: | Olson, Luke M., |
---|---|
Other Authors: | Wendling, Brett W.,, United States. Federal Trade Commission. Bureau of Economics, |
Format: | eBook |
Language: | English |
Published: |
Washington, DC :
Bureau of Economics, Federal Trade Commission,
2013.
|
Physical Description: |
1 online resource (41 unnumbered pages) : illustrations. |
Series: |
Working paper (United States. Federal Trade Commission. Bureau of Economics) ;
no. 317. |
Subjects: | |
Online Access: |
https://purl.fdlp.gov/GPO/gpo62909 |
In Prospector
Similar Items
-
Generic substitution and prescription drug prices : economic effects of state drug product selection laws
by: Masson, Alison,
Published: (1985) -
Entry threats and pricing in the generic drug industry
by: Wendling, Brett.
Published: (2010) -
Generic drug industry dynamics
by: Reiffen, David A.
Published: (2002) -
Emerging health care issues : follow-on biologic drug competition
Published: (2009) -
Generic substitution and prescription drug prices : economic effects of state drug product selection laws
by: Masson, Alison.
Published: (1985)